4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide has been researched along with Pain, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evans, C; McGuire, B; Pradhan, A; Smith, M; Walwyn, W | 1 |
| Balboni, G; Charfi, I; Mnie-Filali, O; Nagi, K; Pineyro, G; Schiller, PW; Thibault, D; Trudeau, LE | 1 |
2 other study(ies) available for 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide and Pain, Chronic
| Article | Year |
|---|---|
Chronic inflammatory injury results in increased coupling of delta opioid receptors to voltage-gated Ca2+ channels.
Topics: Animals; Arrestins; Benzamides; beta-Arrestin 2; beta-Arrestins; Calcium Channels; Chronic Disease; Chronic Pain; Freund's Adjuvant; Ganglia, Spinal; Hyperalgesia; Inflammation; Ion Channel Gating; Mice; Mice, Knockout; Pain Threshold; Piperazines; Receptors, Opioid, delta | 2013 |
Ligand- and cell-dependent determinants of internalization and cAMP modulation by delta opioid receptor (DOR) agonists.
Topics: Analysis of Variance; Benzamides; Benzimidazoles; Blotting, Western; Chronic Pain; Cyclic AMP; Dose-Response Relationship, Drug; Drug Tolerance; Enkephalin, D-Penicillamine (2,5)-; Fluorescent Antibody Technique; G-Protein-Coupled Receptor Kinase 2; Green Fluorescent Proteins; HEK293 Cells; Humans; Ligands; Neurons; Oligopeptides; Piperazines; Receptors, Opioid, delta | 2014 |